Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.

[1]  M. Jacobs,et al.  The Alexander Project: the benefits from a decade of surveillance. , 2005, The Journal of antimicrobial chemotherapy.

[2]  D. Felmingham.  Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary. , 2005, Journal of chemotherapy.

[3]  Steven D. Brown,et al.  Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance , 2005, Emerging infectious diseases.

[4]  Ronald N. Jones,et al.  Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. , 2005, International journal of antimicrobial agents.

[5]  R. Mera,et al.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. , 2005, Diagnostic microbiology and infectious disease.

[6]  S. Richter,et al.  Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. , 2005, International journal of antimicrobial agents.

[7]  K. O'Brien,et al.  Nasopharyngeal versus Oropharyngeal Sampling for Detection of Pneumococcal Carriage in Adults , 2004, Journal of Clinical Microbiology.

[8]  M. Jacobs.  Streptococcus pneumoniae: epidemiology and patterns of resistance. , 2004, The American journal of medicine.

[9]  J. Karlowsky,et al.  The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. , 2003, Diagnostic microbiology and infectious disease.

[10]  R. Heyderman,et al.  Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. , 2003, International journal of antimicrobial agents.

[11]  R. Hasbún,et al.  Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Marrero,et al.  Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  G. Rubenfeld,et al.  The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. , 2001, The Journal of infectious diseases.

[14]  M. Joloba,et al.  High prevalence of carriage of antibiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda. , 2001, International journal of antimicrobial agents.

[15]  M. Cetron,et al.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.

[16]  N. French,et al.  23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial , 2000, The Lancet.

[17]  Widdowson Ca,et al.  Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. , 1999 .

[18]  K. Klugman,et al.  Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[19]  N. Nagelkerke,et al.  Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection. , 1997, The Pediatric infectious disease journal.

[20]  D. Musher,et al.  Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. , 1997, The Journal of infectious diseases.

[21]  J. Paul,et al.  Streptococcus pneumoniae resistant to penicillin and tetracycline associated with HIV seropositivity , 1995, The Lancet.

[22]  B. Rudensky,et al.  Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature. , 1987, Israel journal of medical sciences.

[23]  E. BeatriceHervé.  Streptococcus pneumoniae bacteremia: Duration of previous antibiotic use and association with penicillin resistance. Ruhe J J, Hasbun R. Clin Infect Dis 2003, May 1; 36 (9): 1132-8 . , 2003 .

[24]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[25]  K. Klugman,et al.  Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. , 2000, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  K. Klugman,et al.  Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. , 1999, Seminars in respiratory infections.